Mersana, Janssen Come Together in Potential $1B ADC Deal
Summary : On Thursday, Mersana Therapeutics signed a research and licensing deal with Janssen Biotech to access each other’s proprietary technology in…
Summary : On Thursday, Mersana Therapeutics signed a research and licensing deal with Janssen Biotech to access each other’s proprietary technology in…
KEYPOINTS: Janssen has won approval from the European Commission for Byannli, a six-month formulation of Paliperidone Palmitate, two months after receiving a…
SUMMARY: ViiV Healthcare announces the European Commission Decision for Vocabria (Cabotegravir) and Rekambys (Rilpivirine) injections to be initiated with or without an…